KYNTRA BIO INC
KYNBNASDAQ🏆 #4632 by market capEarnings Nov 9 · PostUS Equity
$4.72▲ $0.22 (+4.89%)
Pre-market · at closeTrack KYNB
Get earnings, price moves & breaking news on Telegram
24h▲ 4.9%
7d▼ 9.6%
14d▼ 16.5%
30d▼ 34.9%
ytd▼ 46.1%
1y▼ 56.4%
🏦Market Cap
$19M
Small Cap
📈Revenue Growth (YoY)
-91.4%
Declining
📊Gross Margin
40.7%
Healthy
💵FCF Margin
333.0%
Strong
⚖️P/S Ratio
3.9x
Fair
Otter Score
—
Insufficient data
Earnings
Q3 · 2026Reported 2026-08-13Earnings Per Share
Actual
2.96
Expected
-3.18
beat
+193.10%
YoY +187.60%
Revenue
Actual
−$1.50M
Expected
$2.09M
miss
−171.80%
YoY −215.40%
Consensus estimates
Recent quarters
Q3 2026
2.96
beat
Q2 2026
-3.74
miss
Q1 2026
-3.51
beat
Q4 2025
-1.61
beat